Mannkyu Hong
Mannkyu Hong
Verified email at
Cited by
Cited by
Design and optimization of catalysts based on mechanistic insights derived from quantum chemical reaction modeling
S Ahn*, M Hong*, M Sundararajan, DH Ess, MH Baik
Chemical reviews 119 (11), 6509-6560, 2019
Mechanistic investigation of bis (imino) pyridine manganese catalyzed carbonyl and carboxylate hydrosilylation
TK Mukhopadhyay, CL Rock, M Hong, DC Ashley, TL Groy, MH Baik, ...
Journal of the American Chemical Society 139 (13), 4901-4915, 2017
Scorpionate Catalysts for Coupling CO2 and Epoxides to Cyclic Carbonates: A Rational Design Approach for Organocatalysts
M Hong*, Y Kim*, H Kim, HJ Cho, MH Baik, Y Kim
The Journal of Organic Chemistry 83 (16), 9370-9380, 2018
Ring-truncated deguelin derivatives as potent Hypoxia Inducible Factor-1α (HIF-1α) inhibitors
HS Kim, M Hong, SC Lee, HY Lee, YG Suh, DC Oh, JH Seo, H Choi, ...
European journal of medicinal chemistry 104, 157-164, 2015
Understanding the origin of the regioselectivity in cyclopolymerizations of diynes and how to completely switch it
H Jung, K Jung, M Hong, S Kwon, K Kim, SH Hong, TL Choi, MH Baik
Journal of the American Chemical Society 140 (2), 834-841, 2018
Synthesis and biological evaluation of C-ring truncated deguelin derivatives as heat shock protein 90 (HSP90) inhibitors
HS Kim, M Hong, J Ann, S Yoon, CT Nguyen, SC Lee, HY Lee, YG Suh, ...
Bioorganic & Medicinal Chemistry 24 (22), 6082-6093, 2016
Multiple reactivities of flavonoids towards pathological elements in Alzheimer's disease: structure–activity relationship
G Nam*, M Hong*, J Lee, HJ Lee, Y Ji, J Kang, MH Baik, MH Lim
Chemical science 11 (37), 10243-10254, 2020
Investigation of B, C-Ring Truncated Deguelin Derivatives as Heat Shock Protein 90 (HSP90) Inhibitors for Use as Anti-Breast Cancer Agents
HS Kim, VH Hoang, M Hong, KC Kim, J Ann, CT Nguyen, JH Seo, H Choi, ...
Bioorganic & medicinal chemistry 27 (7), 1370-1381, 2019
Pyridine C-region analogs of 2-(3-fluoro-4-methylsulfonylaminophenyl) propanamides as potent TRPV1 antagonists
HC Ryu, S Seo, JY Lee, TH Ha, S Lee, A Jung, J Ann, SE Kim, S Yoon, ...
European journal of medicinal chemistry 93, 101-108, 2015
Understanding the mechanism of direct visible-light-activated [2+ 2] cycloadditions mediated by Rh and Ir photocatalysts: combined computational and spectroscopic studies
H Jung, M Hong, M Marchini, M Villa, PS Steinlandt, X Huang, ...
Chemical Science 12 (28), 9673-9681, 2021
α-Substituted 2-(3-fluoro-4-methylsulfonamidophenyl)acetamides as potent TRPV1 antagonists
PT Tran, HS Kim, J Ann, SE Kim, C Kim, M Hong, VH Hoang, VTH Ngo, ...
Bioorganic & medicinal chemistry letters 25 (11), 2326-2330, 2015
S-lactoyl modification of KEAP1 by a reactive glycolytic metabolite activates NRF2 signaling
Y Ko*, M Hong*, S Lee*, M Kumar, L Ibrahim, K Nutsch, C Stanton, ...
Proceedings of the National Academy of Sciences 120 (20), e2300763120, 2023
Excited-State Intramolecular Hydrogen Transfer of Compact Molecules Controls Amyloid Aggregation Profiles
M Hong*, M Kim*, J Yoon, SH Lee, MH Baik, MH Lim
JACS Au 2 (9), 2001-2012, 2022
Discovery of N-(1-(2-hydroxyethyl) quinolin-2-one)-N’-(1-phenyl-1H-pyrazol-5-yl) methyl) urea as Mode-Selective TRPV1 antagonist
D Zuo, M Hong, A Jung, S Lee, N Do, S Jung, Y Jeon, JW Jeong, ...
Bioorganic & Medicinal Chemistry Letters, 129656, 2024
Designing multi-target-directed flavonoids: a strategic approach to Alzheimer's disease
S Park, M Kim, Y Lin, M Hong, G Nam, A Mieczkowski, J Kardos, YH Lee, ...
Chemical Science 14 (35), 9293-9305, 2023
Unveiling the impact of oxidation-driven endogenous protein interactions on the dynamics of amyloid-β aggregation and toxicity
Z Du, E Nam, Y Lin, M Hong, T Molnár, I Kondo, K Ishimori, MH Baik, ...
Chemical Science 14 (20), 5340-5349, 2023
The system can't perform the operation now. Try again later.
Articles 1–16